WHO ICTRP trial
Efficacy Comparison of Dostarlimab Plus Chemotherapy vs Pembrolizumab Plus…
EUCTR2020-002327-11-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-002327-11-FR |
|---|---|
| Public title | Efficacy Comparison of Dostarlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy in Participants with Metastatic Non squamous Non small Cell Lung Cancer |
| Scientific title | A RANDOMIZED, PHASE 2, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY OF DOSTARLIMAB PLUS CHEMOTHERAPY VERSUS PEMBROLIZUMAB PLUS CHEMOTHERAPY IN METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER |
| Primary sponsor | GlaxoSmithKline Research & Development Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Argentina;Romania;United States;Brazil;Korea, Republic of;Poland;Italy;France;Germany;Spain |
| Conditions | Metastatic non-squamous non-small cell lung cancer MedDRA version: 21.1 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and… |
| Interventions | Product Name: Dostarlimab Product Code: TSR-042, GSK4057190 Pharmaceutical Form: Solution for infusion INN or Proposed INN: Dostarlimab CAS Number: 2022215-59-2 Current Sponsor code: GSK4057190 Other descriptive name: Dostarlimab (50 mg/mL)… |
| Registration date | Nov 25, 2020 |
| Target size | 240 |
| Secondary IDs | 213403;2020-002327-11-DE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: